Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Sponsor: Adverum Biotechnologies, Inc.
Summary
ADVM-022-07 is an observational long-term extension (OPTIC-EXT) study assessing safety and efficacy of ADVM-022 gene therapy product, in participants with neovascular, or exudative (wet), age-related macular degeneration (nAMD).
Official title: A Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
23
Start Date
2020-12-14
Completion Date
2030-06-26
Last Updated
2026-02-10
Healthy Volunteers
No
Interventions
ADVM-022
Long term follow-up of subjects that received ADVM-022
Locations (9)
Adverum Clinical Site
Bakersfield, California, United States
Adverum Clinical Site
Beverly Hills, California, United States
Adverum Clinical Site
Lakewood, Colorado, United States
Adverum Clinical Site
Deerfield Beach, Florida, United States
Adverum Clinical Site
Reno, Nevada, United States
Adverum Clinical Site
Philadelphia, Pennsylvania, United States
Adverum Clinical Site
Nashville, Tennessee, United States
Adverum Clinical Site
Bellaire, Texas, United States
Adverum Clinical Site
The Woodlands, Texas, United States